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NF-,cB and transcriptional control of renal epithelial-inducible nitric
oxide synthase. Expression of the inducible isoform of nitric oxide
synthase (iNOS) is subject to strict tissue specific transcriptional control.
Recently, the NF-KBIRel family of transcription factors, and particularly
c-rel, was shown to mediate bacterial lipopolysaccharide (LPS) induction
of iNOS in macrophages. Since LPS is only a weak inducer of iNOS in
most nonimmune cells, we investigated the role of NF-KB in the regulation
of iNOS expression in mouse renal epithelial cells. We report that LPS
activates NF-KB in renal epithelium, but that this is not sufficient for
induction of iNOS activity. The NF-KB complexes activated by LPS in
renal epithelium differ from those in macrophages in that they lack c-rel,
which may explain the absence of iNOS induction in renal epithelium.
Conversely, LPS and interferon-y (IFN) synergize to induce renal epithe-
ha! iNOS. Functional iNOS promoter analysis indicate that this synergistic
induction requires NF-KB. We conclude that NF-KB is necessaiy but not
sufficient for the induction of renal epithelial iNOS expression, and that in
contrast to macrophages, c-rd does not appear to play a major role in the
regulation of renal epithelial iNOS.
Expression of the inducible (type II) isoform of nitric oxide
synthase (iNOS) is subject to very strict and highly tissue-specific
transcriptional regulatory control [1, 2]. For example, bacterial
lipopolysaccharide (LPS) induces high levels of iNOS expression
in macrophages and microglia [3—6]. Conversely, only modest
levels of iNOS induction occurs in hepatocytes, vascular smooth
muscle and renal epithelial cells after stimulation with LPS or
single cytokines, and a combination of two or more of these
inducers is commonly required for full expression of iNOS activity
[6—8]. Thus, the expression of iNOS appears to be regulated
differently in parenchymal cells than in cells such as macrophages
and brain microglia whose main role is to mediate immune
responses.
Recently, Xie and collaborators reported that the transcrip-
tional activation of macrophage iNOS by LPS is dependent on the
nuclear translocation of NF-KB [9]. NF-KB proteins are an
ubiquitous group of transcription factors that exist mainly as
inactive dimers in the cytoplasm of cells bound to inhibitory
proteins known as inhibitors of kappa-B (1KB) [101. Upon cell
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activation 1KB dissociates from the NF-KB dimer, allowing this to
migrate to the nucleus where it binds to the promoter region of
various genes and initiates transcription [10]. The induction of
macrophage iNOS by LPS is dependent on the activation of
NF-KB heterodimers containing mainly c-rel and p65 proteins [9].
The c-re! component of NF-KB had previously been reported to
have only modest transactivating activity [9, 10] and therefore,
transactivation of the iNOS gene constitutes an important novel
role for this NV-KB protein in macrophages.
Renal tubular epithelium has recently been found to express
iNOS [8, 11], but the regulation of this enzyme in the kidney has
not been extensively investigated. The present study was designed
to study the transcriptional regulation of renal epithelial iNOS
and to characterize the role of NF-KB in the induction of this
enzyme by LPS and gamma-interferon (IFN) in renal epithelium.
We report that combined LPS and IFN treatment induce tran-
scriptional activation of renal epithelial iNOS. In addition, we
report that LPS alone causes only minimal induction of INOS
despite marked activation of NF-KB, and that the NF-KB com-
plexes translocated to the nucleus after LPS treatment do not
contain c-re! protein. This latter finding may explain why, as
opposed to its effects in macrophages, LPS is only a weak inducer
of iNOS in renal epithelium, and suggests that c-rel may be an




Murine proximal convoluted tubule (MCT) cells were grown in
Dulbecco's modified Eagle's medium supplemented with 5% fetal
bovine serum, 25 m Hepes buffer, 10 .LM non-essential amino
acids and 100 M sodium pyruvate. L-Arginine concentration in
this medium is 84 mg/liter. The cultures were maintained at 37°C
in a 5% C02/95% 02 environment. The MCT cell lines were
kindly provided by Dr. Eric Neilson (University of Pennsylvania,
PA, USA). These cells were established from microdissected
mouse proximal tubules after stabilization by transfection with
SV4O virus and they maintain many of the properties of differen-
tiated proximal tubule epithelial cells [12]. The mouse macro-
phage cell line RAW 264.7 was obtained from American Type
Culture Collection (Rockville, MD, USA) and grown in Roswell
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Park Memorial Institute (RPMI) 1640 medium supplemented
with 10% fetal bovine serum and 2 mrvi L-glutamine.
Reagents
Dulbecco's modified Eagle's medium (DMEM), RPMI and all
other cell culture materials were purchased from Fisher Scientific
(Orlando, FL, USA). Interferon-y (IFN, rat recombinant) was
purchased from Gibco BRL (Gaitherburg, MD, USA). Lipopoly-
saccharide (LPS, E. co/i serotype 026:B6), pyrrolidine dithiocar-
bamate, sulfanilamide, sodium nitrite, N-(1-naphthyl) ethylenedi-
amine hydrochloride and N-nitro-L-arginine (NNA), and other
general chemical reagents were purchased from Sigma Chemical
Co. (St. Louis, MO, USA).
Nitrite assay
Nitrites were measured by the addition of 200 .tl of freshly
prepared Greiss reagent (0.75% sulfanilamide in 0.5 N HCI and
0.075% N-(1-naphthyl)ethylenediamine dihydrochioride in dou-
ble distilled water) to 200 p1 of the culture medium from treated
and control cells, followed by spectrophotometric absorbance
readings at 543 nm (Beckman DU 650) [13]. Nitrite concentra-
tions were determined by comparisons with a standard sodium
nitrite curve with double distilled water as blank and expressed as
nanomoles per mg of protein. Protein concentrations were mea-
sured by the method of Lowry et al [14].
Preparation of nuclear extracts
Nuclear extracts were prepared using a modification of a
previously described procedure [15]. Briefly, control and experi-
mentally treated MCT cells were scraped in ice-cold PBS, har-
vested by centrifugation at 500 g for 10 minutes and homogenized
in two packed cell volumes (PCV) of hypotonic buffer (Tris-HCI
10 mM, pH 7.4, KCI 10 mM, MgCl2 3 mi, dithiothreitol (DTT) 1
mM, PMSF 0.5 mi, leupeptin 2 /LM) using a glass tissue grinder
with a Teflon pestle. The homogenates were centrifuged at 500 g
for 10 minutes and the nuclei pellet obtained from approximately
i0 cells was resuspended in 3 ml of extraction buffer (Tris-HC1 10
mM, pH 7.4, KCI 0.3 M, MgC12 3 mivi, DTT 1 mri, PMSF 0.5 mM,
leupeptin 2 M and glycerol 20% vol/vol) and kept on ice for 45
minutes with gentle rocking. The extract was then clarified by
centrifugation at 25,000 g for 30 minutes. The clear supernatant
was dialyzed against 50 volumes of dialysis buffer (Tris-HC1 10
mM, pH 7.4, KC1 0.1 M, DTT 1 mvi, PMSF 0.5 mi, leupeptin 2 j.M,
EDTA 0.2 m, glycerol 20% vol/vol) for one hour, centrifuged at
25,000 g and aliquots were stored at —70°C for subsequent use.
Oligonucleotide probes and electrophoretic mobilily gel shift assay
The NF-KB consensus DNA binding site is formed by the
general decameric motiff 5'-GGGRNNTYCC [10]. We utilized a
double-stranded consensus oligonucleotide containing the se-
quence 5'-GGGACTTTCC and radiolabeled by phosphorylation
with [y-32P] ATP (3,000 Ci/mmol) using T4 polynucleotide kinase
(Promega Corporation, Madison, WI, USA) following standard
protocols [161.
Electrophoretic mobility gel shift assays (EMSA) were per-
formed following previously published protocols [91 with minor
modifications. The binding reaction was carried out by adding 10
tg of nuclear protein to binding buffer (Tris-HC1 10 mrvi, pH 7.5,
MgCI2 1 m, EDTA 0.5 mrvt, DIT 0.5 mrvi, NaCl 50 m, glycerol
4% and poly (dI-dC)-poly (dI-dC) 50 jig/ml containing the [y-32P]
ATP-labeled NF-KB oligonucleotide probe in a total volume of 10
p1. The mixture was incubated at room temperature for 20
minutes and electrophoresis was then carried out on a 4%
nondenaturing polyaciylamide gel for three hours at 100 V
followed by autoradiography of the dried gel. Individual NF-KB
proteins were identified by the presence of supershift or the
dissapearance of the original NF-KB complexes in EMSA after
addition of specific polyclonal lgG antibodies against p50, p65 and
c-rel (Santa Cruz Biotechnology, Santa Cruz, CA, USA) to the
binding reaction [9, 17].
Western analysis
Expression of iNOS protein was determined by Western anal-
ysis using a monoclonal antibody against macrophage iNOS
(Transduction Laboratories, Lexington, KY, USA) and following
standard protocols [161. Briefly, MCT cells were lysed on culture
dishes in 20 mivi Tris-HC1, pH 7.5, containing 0.1 mivi PMSF, 2 m
EDTA, 0.5 mM EGTA, 10 .tg/ml leupeptin and 1 /Lg/ml aprotinin,
centrifuged at 1000 rpm for five minutes and homogenized on ice
with 30 strokes in an Eppendorf cube with a disposable homog-
enizer. Cell proteins were solubilized in SDS, separated by
discontinuous polyacrylamide gels (5% stacking gel, 7.5% resolv-
ing gel, 40 mA for five hours), and transferred to 0,45 mivi
nitrocellulose membrane in 25 mrvt Tris, pH 8.3, 150 mM glycine,
and 20% vol/vol methanol for 15 hours at 100 mA. The nitrocel-
lulose membranes were blocked with 10% nonfat dry milk in PBS
for two hours and subsequently incubated with iNOS antibodies
(1/250) for four hours at 20°C. After washing the membranes to
remove excess antibody, peroxidase-conjugated secondary anti-
bodies were applied and the protein of interest identified by
enhanced chemiluminescence (ECLTM, Amersham Corporation,
Arlington Heights, IL, USA).
Northern analysis
Total RNA was isolated by acid-phenol extraction [18]. The
RNA samples were separated on an agarose gel containing 2.2 M
formaldehyde, transferred to a Nytran nylon membrane (Schlei-
cher and Schuell, Keene, NH, USA) and cross-linked by exposure
to UV light. Membranes were hybridized with a random prime
labeled ([32PIdCTP) full-length murine macNOS-cDNA [5, 19,
201 overnight at 55°C followed by washing under low stringency
conditions (2 x SSPE, 0.2% SDS, 65°C) and a high stringency
wash (0.1 x SSPE, 65°C), and exposed to autoradiography.
Ribosomal (18 s) RNA was used as RNA gel loading control.
Cloning of the upstream promoter region of the iNOS gene
The 1749-base upstream promoter region of the iNOS gene was
cloned from mouse genomic DNA by polymerase chain reaction
(PCR) [16] using the primers 5'-AGA AGC TITG ACT TITG ATA
TGC ATA TGC TGA AAT CCA T complementary to the 5' end,
and 5'-GAG TCG ACG AAC AAG ACC CAA GCG TGA GGA
A complementary to the 3' end of the promoter. These primers
were chosen based on the previously published sequence of the
mouse iNOS promoter [4]. The 1749-base PCR product corre-
sponding to the region between —1588 and +161 of the mouse
iNOS gene was then inserted into a pCAT-Basic vector (Promega
Corporation, Madison, WI, USA) upstream of the promoterless
chioramphenicol acetyltransferase (CAT) gene between the
HindIII and Sail sites to form the plasmid construct pAiNOS-
CAT. Sequencing of the PCR product showed this to be almost
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identical with the previously published iNOS promoter sequence.
Only four-bases were found to be different (G for C in positions
—603, —605 and —607, and A for C in position —254) and these
occurred in regions outside of any described putative transcription
factor consensus binding sites [4].
Transient transfection and chloramphenicol acetyltransferase
(CAT) reporter gene assay
Transient transfection of MCT cells and CAT assays were
performed following previously published protocols [21]. Briefly,
plasmids pAiNOS-CAT and pCAT-Control (used as transfection
control) (Promega Corporation, Madison, WI, USA) were trans-
fected into MCT cells using the calcium-phosphate method. Ten
micrograms of plasmid DNA were mixed with 500 l of 124 mM
CaC12 and this solution added dropwise to 500 jsl of 50 mM
HEPES (pH 7.1), 280 mrvi NaC1 and 1.5 mvi Na2HPO4. Precipi-
tation was allowed to occur over 30 minutes at room temperature
and the DNA-calcium-phosphate precipitate was then added
dropwise to MCT cells in culture, followed by overnight incuba-
tion at 37°C in 5% CO2. At the end of this period, MCT cells were
washed with PBS and returned to complete DMEM medium.
After 24 hours, the medium was changed and the cells treated
with a combination of LPS (1 g/ml) and IFN (100 U/mI) for an
additional 24-hour period. The cells were then washed with
ice-cold PBS, resuspended in 0.25 mrvi Tris (pH 7.8), and sub-
jected to three cycles of freezing and thawing. Lysates were then
centrifuged at 11,700 g for 10 minutes at 4°C. The supernatant was
heated at 65°C for 10 minutes to inactivate CAT inhibitors and
then centrifuged as above. The supernatant was then assayed for
CAT activity by the thin layer chromatography (TLC) method [22]
using an assay mixture (Promega Corporation) containing (final
vol 180 .il) 100 g of cell extract (in 20 dxl), 100 uI of 0.25 mrvi Tris
(pH 7.5), 1 u1 (1 uCi) of [14C}-chloramphenicol (50 utCi/mmol)
and 20 u1 of 4 m'vi acetyl coenzyme A. After autoradiography of
the TLC plates, spots containing acetylated and nonacetylated
chloramphenicol forms were cut out and counted for radioactivity.
CAT activity is expressed as the ratio of acetylated to nonacety-
lated chloramphenicol (% acetylation).
Experimental design and statistical analysis
Where indicated, statistical analysis was performed using Stu-
dent's t-test for paired and unpaired data, or analysis of variance
(ANOVA) and subsequent Scheffe's F-test (StatView IV, Aba-
cus Concepts, Inc. Berkeley, CA, USA) for multiple group
comparisons as appropriate. The results are presented as mean
standard error of the indicated number of experiments performed
in triplicate samples. Each blot shown is a representative example
of a series of experiments performed on at least three separate
occasions.
Results
Treatment of MCT cells with LPS (1 ug/ml for 24 hr) failed to
stimulate nitrite production. IFN (100 U/ml), which by itself was
also ineffective in stimulating nitrite production, potently syner-
gized with LPS to stimulate iNOS activity (Fig. 1). Combined
treatment with LPS and IFN was accompanied by a marked
time-dependent increase in steady-state iNOS mRNA levels










Fig. 1. Nitrite production in MCT cells treated with LPS (1 ig/ml), IFN
(100 U/mI) or their combination for 24 hours. * P < 0.001, N = 9. I 8s —
Control LPS IFN LPS/IFN
Fig. 2. iNOS mRNA expression in MCT cells treated with a combination of
LPS (1 pg/mI) and IFN (100 U/mI) for the indicated periods of time, or with
each of these agents alone for six hours.
z
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Fig. 3. iNOS protein expression in MCT cells before and after 12 hours of
treatment with LPS (1 pg/mI) alone or in combination with IFN (100 U/ml).
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Fig. 4. Time course of the effects of IFN (100 U/mi), LPS (1 pg/mI) and their combination on the nuclear transiocation of NF-.B in MCT cells. Control
untreated cells possess low basal nuclear levels of NF-KB; "+ comp" indicates that the binding reaction was carried out in the presence of 100-fold excess
of unlabeled NF-KB oligonucleotide; "+ noncomp" indicates that this reaction was carried out in the presence of 100-fold excess of an irrelevant (APi)
oligonucleotide. Both competition and noncompetition controls were performed with nuclear extracts from cells treated with a combination of LPS and
IFN for 60 minutes.
FN — + + — — + +
LPS — — — + + + +
PDTC + — + + +
Fig. 5. Effect of PDTC (25 pM) on the nuclear transiocation of NF-,B in MCT cells treated with IFN (100 U/mi), LPS (1 pg/mi) or their combination for
30 minutes. PDTC treatment was initiated 30 minutes before IFN and LPS were added and maintained during the 30 minutes of induction.
at six hours and decreased after 24 hours (Fig. 2). LPS treatment
caused only a small increase in iNOS mRNA whereas none was
detected when the cells were treated with IFN alone. However,
despite a small increase in iNOS mRNA, LPS failed to induce
detectable levels of iNOS protein (Fig. 3). Conversely, the com-
bination of LPS and IFN resulted in a marked increase in iNOS
(Fig. 3).
To determine whether either LPS or IFN can activate NF-,B in
renal epithelium, we extracted nuclear proteins from MCT cells
treated with each of these agents alone or in combination, and
analyzed these extracts by EMSA using an NF-KB consensus
oligonucleotide. As illustrated in Figure 4, both treatment with
IFN or LPS alone caused rapid nuclear translocation of NF-KB.
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Fig. 6. Effect of PDTC (25 thf) on iNOS mRNA expression (A) and iNOS protein levels (B) in MCT cells treated with a combination of LPS (1 sg/ml) and
IFN (100 U/mI). Cells were incubated with PDTC for 30 minutes before the addition of LPS and IFN, and during the entire induction period. iNOS


















Fig. 7. Effect of PDTC (25 jIM) on nitrite production by MCT cells treated
with a combination of LPS (1 pg/ml) and IFN (100 U/mI) for 24 hours. Cells
were incubated with PDTC for 30 minutes before the addition of LPS and
IFN, and during the entire induction period.
transcription factor. Moreover, the addition of IFN did not
potentiate the activation of NF-KB caused by LPS. Thus, these
results indicate that both LPS and IFN can activate NF-KB in
renal epithelium. However, this activation is not sufficient for
induction of 1NOS.
To investigate the potential role of NF-KB in the induction of
iNOS expression by LPS and IFN, we studied the effects of the





Fig. 8. Effect of PDTC on the activation of the iNOS promoter by LPS and
[EN. MCT cells transfected with pAINOS-CAT vector were treated with a
combination of LPS (1 sg/ml) and IFN (100 U/mI) for 24 hours in the
absence (—) or presence (+) of 25 rM PDTC, and this was followed by
CAT assay of cell lysates (* P <0.05 vs. Control; ** P<0.005 vs. LPS/IFN
in the absence of PDTC; N = 3).
illustrated in Figure 5, treatment with PDTC (25 jIM) inhibited the
activation of NF-KB by IFN, LPS and their combination. In
addition, PDTC markedly inhibited the expression of iNOS
mRNA and iNOS protein induced by LPS and IFN (Fig. 6), and
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Fig. 9. Characterization of NF-KB proteins activated by LPS in RAW264. 7macrophages (A) and MCTcells (B). Nuclear extracts obtained after 30 minutes
of treatment with LPS (1 zg/mI) were analyzed by EMSA in the absence or presence of IgG against p50, p65 and c-re!. Marked activation of NF-KB
is observed after LPS treatment. In RAW 264.7 macrophages (A), addition of p50 IgG results in "supershift" with the appearance of an intense
slower-migrating band consistent with the presence of p50 protein. Addition of p65 IgG also results in "supershift" with appearance of a less intense
band that migrates slower than the p.50 complex. Addition of c-re! IgG results in marked reduction of the NF-KB complex and "supershift" with
appearance of a band that migrates similarly to p65. These findings are consistent with the presence of a substantial amount of c-re! protein in the nuclei
of LPS-treated RAW 264.7 macrophages. In MCT cells (B), addition of p50 and p65 IgG results in "supershift" consistent with the presence of p50 and
p65 proteins, respectively. However, addition of c-rel IgG fails to induce "supershift" or to substantially affect the NF-KB complex indicating the absence
of significant amounts of c-re! in the nuclei of LPS-treated MCT cells.
IFN LPS/IFN
CD U) a) 0 U) Cl)It) CO U) (0
I 0- 0 I 0. 0. 0
Fig. 10. Characterization of NF-sB proteins activated by JFN (A) and the combination of LPS and IFN (B) in MCT cells. Nuclear extracts obtained after 30
minutes of treatment with IFN alone (100 U/mI) or a combination of LPS (1 j.g/mJ) and IFN were analyzed by EMSA in the absence or presence of IgG against
p50, p65 and c-re!. Both treatments activate p50 and p65 but fail to activate significant amounts of c-re!. IFN is a weaker inducer of p65 translocation than LPS.
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prevented the formation of nitrites (Fig. 7). Cell viability assessed
by trypan blue exclusion was consistently greater than 90% under
all experimental conditions studied.
To examine in a more direct manner whether transcriptional
induction of renal epithelial iNOS required activation of NF-icB,
we transfected the pAiNOS-CAT construct formed by the fusion
of the iNOS promoter with the CAT gene into MCT cells, and
subsequently treated these cells with a combination of LPS and
IFN in the presence or absence of PDTC. CAT assays performed
after 24 hours of treatment showed a significant (twofold) in-
crease in CAT activity in LPS/IFN-induced cells which was
completely prevented by PDTC (Fig. 8). Thus, these results
indicate that NF-KB is necessary for renal epithelial iNOS induc-
tion.
To identify the components of NF-KB activated by LPS in renal
epithelium and compare them to those activated in macrophages
in which LPS is known to be a potent inducer of iNOS, we used
IgG against the three major NF-KB components, p50, p65 (Rel A)
and c-rel, in an EMSA. Consistent with a previous report by Xie
and collaborators [9], LPS activated NF-KB complexes containing
p50, p65 and c-rel in the mouse macrophage cell line RAW 264.7
(Fig. 9A). The combination of c-rel and p65 IgG resulted in
almost total disappearance of the LPS-induced NF-KB complex in
these cells (not shown). The formation of p65/c-rel heterodimers
has been reported to be important in mediating the transactiva-
tion of iNOS in macrophages [9]. Treatment of MCT cells with
LPS resulted in activation of NF-KB complexes containing p65
and p50 proteins (Fig. 9B). The activation of p65 appeared to be
greater in MCT cells than in RAW 264.7 macrophages. However,
contrary to what occurs in macrophages, c-rel was not observed in
renal epithelium. The addition of c-rel IgG to either p50 or p65
IgG failed to affect the respective NF-KB complexes (not shown).
These results suggest that c-re! may in fact be a major determinant
of the tissue specificity of LPS-induced iNOS responses.
To determine whether the synergism of LPS and IFN on renal
epithelial iNOS induction could be related to interactions be-
tween different NF-KB proteins activated selectively by each of
these agents (such as LPS activating p50 and p65, and IFN
activating c-rel), we compared the effects of LPS, IFN, and
combined LPS and IFN treatment on the activation of NF-KB
proteins. The profile of NF-KB components activated by IFN and
by the combination of LPS and IFN was similar to that observed
after LPS treatment alone (Fig. 10). IFN also failed to activate
c-re! and seemed to be a weaker inducer of p65 trans!ocation than
LPS. Thus, these results indicate that the synergism between LPS
and IFN is not due to complementary effects of the activation of
different NF-KB proteins by each of these agents.
Discussion
Using functional analysis of the iNOS promoter, we report in
the present study that expression of mouse renal epithelial iNOS
is subject to direct transcriptional regulatory control. To our
knowledge, this is the first direct demonstration of transcriptional
regulation of iNOS in a tissue of renal origin. We also report that
NF-KB is necessary for the transcriptional induction of renal
epithelial INOS by LPS and IFN acting possibly as a mediator of
the synergism between these two inducers. Both LPS and IFN
cause rapid nuclear translocation of NF-KB complexes composed
of p65 (Rel A) and p50 protein. Contrary to what occurs in
macrophages in which LPS is a potent inducer of iNOS activity, no
c-re!-containing NF-KB complexes were observed after treatment
with LPS, IFN or their combination.
An interesting finding of the present study is that despite the
fact the both LPS and IFN individually induced the translocation
of NF-KB complexes, IFN failed to induce iNOS mRNA, whereas
LPS caused only a small increase in iNOS mRNA levels which was
not followed by a detectable increase in either iNOS protein or
nitrite production. These results appear to indicate that nuclear
translocation of NF-KB alone is not sufficient to induce iNOS
activity in renal epithelium. One possible explanation for this
failure to induce iNOS activity is the absence of c-rel in the NF-KB
complexes activated by both LPS and IFN. This is consistent with
the notion that the ability of the various components of NF-KB to
associate and form multiple different dimers appears to be a
major determinant of the ability of these proteins to assign tissue
specific responses to a given stimulus [23]. However, inhibition of
NF-KB with PDTC completely prevented the induction of iNOS
activity observed after combined LPS and IFN treatment. This
indicates that, although NF-KB activation may not be sufficient for
iNOS induction in renal epithelium, it is, however, a necessary
requirement for this process. Therefore, another possible expla-
nation for the lack of iNOS induction during LPS or IFN
treatment alone could be that activation of other as yet uniden-
tified non-Re! proteins that interact with NF-KB may be necessary
for transactivation of the iNOS gene. Recent studies indicate that
certain proteins such as NF-1L6, Tax and HMG 1(Y) interact with
NF-KB and possibly function as necessary accessory proteins for
transactivation of the IL-6 [241, HTLV-1 [25] and IFN-j3 [26]
genes, respectively. In fact, Xie, Kashiwabara and Nathan have
suggested that, in addition to c-rel, activation of other non-Rel
proteins is also necessary for iNOS induction in macrophages [9].
An alternative explanation for the failure of LPS to induce iNOS
in renal epithelial cells could be that the p50/p65-containing
NF-KB dimers that are translocated to the nucleus are unable to
interact with their cognate KB binding sites in the INOS promoter.
It was recently reported that p50 homodimers can show strong
constitutive binding to KB sites in the nuclei of resting cells which
prevents the binding of p5O/p65 heterodimers and inhibits trans-
activation [27]. This inhibition can be removed by activation of
Bcl-3, an I-KBa-related oncoprotein which dissociates p50 ho-
modimers from their DNA binding sites [27]. Theoretically, since
a low basal level of nuclear NF-KB activity can be observed in
MCT cells at rest, it is conceivable that this activity may
represent an inhibitory influence and that activation of Bcl-3 by
combined LPS and IFN treatment could release this inhibition
allowing iNOS to be transcribed. Studies are currently under-
way in our laboratory to elucidate the potential role of these
different NF-KB components in the regulation of renal epithe-
hal iNOS expression.
Two intriguing findings of our study are the absence of iNOS
activity after treatment with LPS, and the total blockade of nitrite
formation by PDTC despite the fact that in both cases low levels
of iNOS mRNA can be detected. It is possible that very low levels
of iNOS activity may be present in these situations and that these
are below the detection capabilities of the nitrite assay and
immunoblotting. Alternatively, the iNOS mRNA or protein pro-
duced under these conditions may be highly unstable and unable
to yield functionally active enzyme. In regards to PDTC, we
cannot exclude the possibility that this compound may have other
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as yet undetermined post-transcriptional or post-translational
effects that prevent the expression of iNOS.
The design of our study does not allow us to determine the
mechanism of the synergistic effect of IFN and LPS. However,
unlike what has been previously described in macrophages where
IFN and IL-2 cooperatively activate NF-KB to reach a threshold
level necessary for transactivation of certain genes [28], no such
cooperative interaction was observed between IFN and LPS in
renal epithelium. In addition, from our observations, it does not
appear likely that the synergism between these two agents is due
to activation of different NF-KB components complementing each
other to induce iNOS. In macrophages, interferon regulatory
factor 1 (IRF-1) appears to be necessary for the synergistic induction
of iNOS by IFN and LPS [29], and it is possible that this protein
may also play a role in the regulation of iNOS expression in renal
epithelium. Although our studies may be limited by the fact that
they were performed in transfected renal epithelial cells, it is
noteworthy that similar synergistic interactions between iNOS
inducers have also been observed in murine proximal tubule
epithelial cells grown in primary culture [11, Amoah-Apraku B
and Guzman NJ, unpublished observations]. Further studies are
needed to elucidate the mechanisms of this synergistic interaction.
In conclusion, activation of NF-KB is necessary but not suffi-
cient for the transcriptional induction of iNOS expression by LPS
and IFN in renal epithelium. The absence of c-rel in the NF-KB
complexes translocated by these immunokines may in part ac-
count for their inability to individually induce renal epithelial
iNOS, and therefore c-re! may be a major determinant of the
tissue specificity of iNOS expression. Since NO has been impli-
cated in the pathogenesis of tissue injury during kidney allograft
rejection, autoimmune glomerulonephritis and other disorders [7,
30—33], it will be important to understand the molecular mecha-
nisms that determine the tissue specific regulation of iNOS in
order to identify potential targets for future selective therapeutic
intervention.
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